Menu
Search
|

Menu

Close
X

Baxter International Inc BAX.N (New York Stock Exchange)

75.00 USD
+0.26 (+0.35%)
As of Jul 20
chart
Previous Close 74.74
Open 74.72
Volume 721,013
3m Avg Volume 748,484
Today’s High 75.60
Today’s Low 74.60
52 Week High 75.61
52 Week Low 58.89
Shares Outstanding (mil) 544.87
Market Capitalization (mil) 34,277.83
Forward P/E 38.37
Dividend (Yield %) 0.16 ( 1.02 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.31 Mean rating from 16 analysts

KEY STATS

Revenue (mm, USD)
FY18
2,677
FY17
10,561
FY16
10,163
FY15
9,968
EPS (USD)
FY18
0.706
FY17
2.381
FY16
8.996
FY15
0.714
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
38.37
32.76
Price to Sales (TTM)
vs sector
3.33
5.73
Price to Book (MRQ)
vs sector
3.73
5.47
Price to Cash Flow (TTM)
vs sector
20.32
23.29
Total Debt to Equity (MRQ)
vs sector
37.68
16.84
LT Debt to Equity (MRQ)
vs sector
37.65
12.51
Return on Investment (TTM)
vs sector
6.78
14.61
Return on Equity (TTM)
vs sector
10.22
16.34

EXECUTIVE LEADERSHIP

Jose Almeida
Chairman of the Board, President, Chief Executive Officer, Since 2016
Salary: $1,300,000.00
Bonus: $2,808,000.00
James Saccaro
Chief Financial Officer, Executive Vice President, Since 2017
Salary: $681,658.00
Bonus: $1,108,800.00
Sean Martin
Senior Vice President, General Counsel, Since 2017
Salary: $521,479.00
Bonus: $694,400.00
Jeanne Mason
Senior Vice President - Human Resources, Since 2017
Salary: $540,192.00
Bonus: $1,443,750.00
Giuseppe Accogli
Senior Vice President, President - Global Businesses, Since 2017
Salary: $632,986.00
Bonus: $1,012,000.00

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

1 Baxter Pkwy
DEERFIELD   IL   60015-4625

Phone: +1847.9482000

Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics and biosurgery products. The Renal business offers a portfolio to meet the needs of patients with end-stage renal disease, or irreversible kidney disease and acute kidney injuries, including technologies and therapies for peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapy (CRRT) and additional dialysis services. Its products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices and by patients at home under physician supervision.

SPONSORED STORIES